SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Income Statement
Europe - Frankfurt Stock Exchange - FRA:1SXP - DE000A3ENQ51 - Common Stock
18.56 EUR
+0.12 (+0.65%)
| TTM (2025-6-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 975.68M | 957.09M | 898.60M | 821.10M | 648.70M | |||
| Minority Interest Expense | -620.00K | -660.00K | -92.00K | -500.00K | -400.00K | |||
| Cost Of Goods | 646.00M | 634.00M | 582.11M | 524.70M | 422.50M | |||
| Gross Profit | 329.08M | 322.61M | 316.49M | 296.40M | 226.20M | |||
| Operating Expenses | 139.66M | 132.99M | 145.31M | 128.40M | 111.30M | |||
| Research and Development | 26.97M | 24.25M | 26.82M | 23.50M | 22.30M | |||
| Selling, General, and Administrative Expenses | 128.00M | 125.00M | 125.51M | 110.70M | 93.00M | |||
| Operating Income | 189.34M | 191.01M | 171.17M | 168.10M | 114.90M | |||
| Interest Income/Expense | 2.22M | -617.00K | 16.68M | 0.00 | 8.40M | |||
| Other Income/Expense | -340.00K | -6.58M | -8.81M | -100.00K | -500.00K | |||
| Non Recurring Items | N/A | 590.00K | 6.75M | -9.70M | 500.00K | |||
| Income Before Taxes | 192.00M | 184.00M | 185.80M | 158.30M | 123.30M | |||
| Income Tax | 43.93M | 34.00M | 33.87M | 32.40M | 22.10M | |||
| Net Income | 147.00M | 150.00M | 151.84M | 125.40M | 100.80M | |||
| EBITDA | 264.33M | 256.01M | 217.82M | 223.50M | 151.30M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.97 | 0.99 | 1.01 | 0.83 | 0.67 | |||
| Non GAAP EPS | 0.97 | 0.99 | N/A | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 33.73% | 33.71% | 35.22% | 36.10% | 34.87% | |||
| Profit Margin | 15.07% | 15.67% | 16.90% | 15.27% | 15.54% | |||
| Operating Profit Margin | 19.41% | 19.96% | 19.05% | 20.47% | 17.71% | |||
All data in EUR